ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Gainers
Why HT&E, JB Hi-Fi, Reece, and ResMed shares are charging higher
Share Market News
ASX 200 (ASX:XJO) midday update: Macquarie doubles profit, ResMed jumps
Share Gainers
ResMed (ASX:RMD) share price jumps 7% on Q1 earnings beat
Share Market News
5 things to watch on the ASX 200 on Friday
Growth Shares
3 buy-rated ASX shares
Blue Chip Shares
2 high quality ASX 200 shares named as buys
Broker Notes
Top broker names 2 of the best ASX shares to buy in October
Broker Notes
5 defensive ASX shares to guide you through the market correction
Broker Notes
Top broker says ResMed (ASX:RMD) share price is a buy
Healthcare Shares
The healthcare sector is weighing on the ASX 200 on Tuesday
Blue Chip Shares
2 top blue chip ASX 200 shares rated as buys
Share Fallers
Why Lake Resources, Ramelius, Telix, & Transurban shares are falling
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
